Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 991 AL 1005

VEGFB is a potential therapeutic target for Alzheimer's disease: Insights from integrative multi-omics analysis

Ye H, Zhuang C, Jin Z, Hu Y, He J, Yu Q, Hu H, Zheng Y.

J Alzheimers Dis. 2025 Dec;108(3):1073-1087. doi: 10.1177/13872877251385244. Epub 2025 Oct 17.

Efficacy and Safety of Natural Apigenin Treatment for Alzheimer's Disease: Focus on In vivo Research Advancements

Zhang N, Nao J, Dong X.

Curr Neuropharmacol. 2025;23(6):728-754. doi: 10.2174/1570159X23666241211095018.

Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO

Puerta R, de Rojas I, García-González P, Olivé C, Sotolongo-Grau O, García-Sánchez A, García-Gutiérrez F, Montrreal L, Tartari JP, Sanabria Á, Pytel V, Lage C, Quintela I, Aguilera N, Rodriguez-Rodriguez E, Alarcón-Martín E, Orellana A, Pastor P, Pérez-Tur J, Piñol-Ripoll G, López de Munain A, García-Alberca JM, Royo JL, Bullido MJ, Álvarez V, Real LM, Corbatón Anchuelo A, Gómez-Garre D, Martínez Larrad MT, Franco-Macías E, Mir P, Medina M, Sánchez-Valle R, Dols-Icardo O, Sáez ME, Carracedo Á, Tárraga L, Alegret M, Valero S, Marquié M, Boada M, Sánchez Juan P, Cavazos JE, Cabrera-Socorro A, Cano A, Ruiz A; Alzheimer’s Disease Neuroimaging Initiative.

Funct Integr Genomics. 2025 Mar 25;25(1):73. doi: 10.1007/s10142-025-01581-6.

Cross-ancestry genome-wide association study identifies implications of SORL1 in cerebral beta-amyloid deposition

Kim JP, Jung SH, Jang B, Cho M, Song M, Kim J, Kim B, Lee H, Shin D, Lee EH, Jang H, Kim BH, Ham H, Kim D, Raj T, Cruchaga C, Kim HJ, Na DL, Seo SW, Won HH.

Nat Commun. 2025 Apr 2;16(1):3150. doi: 10.1038/s41467-025-57751-4.

The whole-brain structural and functional connectome in Alzheimer's disease spectrum: A multimodal Bayesian meta-analysis of graph theoretical characteristics

Liu W, Zuo C, Chen L, Lan H, Luo C, Li X, Kemp GJ, Lui S, Suo X, Gong Q.

Neurosci Biobehav Rev. 2025 Jul;174:106174. doi: 10.1016/j.neubiorev.2025.106174. Epub 2025 Apr 24.

The Footprint of CHASERR as a Potential Culprit in Alzheimer's Disease Patients: An In-Silico-Experimental Study

Khosroabadi Z, Niazmand A, Mousavi SR, Hosseini N, Bagheri N, Chitsaz A, Salehi M.

Curr Alzheimer Res. 2025;22(3):205-218. doi: 10.2174/0115672050381537250422075255.

Identification of 16 novel Alzheimer's disease loci using multi-ancestry meta-analyses

Willett JDS, Waqas M, Choi Y, Ngai T, Mullin K, Tanzi RE, Prokopenko D.

Alzheimers Dement. 2025 Feb;21(2):e14592. doi: 10.1002/alz.14592.

Classification of neuroimaging data in Alzheimer's disease using particle swarm optimization: A systematic review

Dar SA, Imtiaz N.

Appl Neuropsychol Adult. 2025 Mar-Apr;32(2):545-556. doi: 10.1080/23279095.2023.2169886. Epub 2023 Jan 31.

Alzheimer's Disease May Benefit from Olive Oil Polyphenols: A Systematic Review on Preclinical Evidence Supporting the Effect of Oleocanthal on Amyloid-β Load

Zupo R, Castellana F, Panza F, Solfrizzi V, Lozupone M, Tardugno R, Cicero N, Corbo F, Crupi P, Sardone R, Clodoveo ML.

Curr Neuropharmacol. 2025;23(10):1249-1259. doi: 10.2174/011570159X327650241021115228.

Gut microbiota dysbiosis in Alzheimer's disease (AD): Insights from human clinical studies and the mouse AD models

Manfredi JN, Gupta SK, Vyavahare S, Deak F, Lu X, Buddha L, Wankhade U, Lohakare J, Isales C, Fulzele S.

Physiol Behav. 2025 Mar 1;290:114778. doi: 10.1016/j.physbeh.2024.114778. Epub 2024 Dec 11.

Insights on the Characteristics and Therapeutic Potential of Mesenchymal Stem Cell-derived Exosomes for Mitigation of Alzheimer's Disease's Pathogenicity: A Systematic Review

Abdi SMY, Al-Bakri SSM, Nordin N.

Cell Biochem Biophys. 2025 Jun;83(2):1399-1414. doi: 10.1007/s12013-024-01598-x. Epub 2024 Oct 22.

The effect of Amyloid and Tau Co-pathology on disease progression in Lewy body dementia: A systematic review

Tan JH, Laurell AA, Sidhom E, Rowe JB, O'Brien JT.

Parkinsonism Relat Disord. 2025 Feb;131:107255. doi: 10.1016/j.parkreldis.2024.107255. Epub 2024 Dec 24.

Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup

Rabinovici GD, Knopman DS, Arbizu J, Benzinger TLS, Donohoe KJ, Hansson O, Herscovitch P, Kuo PH, Lingler JH, Minoshima S, Murray ME, Price JC, Salloway SP, Weber CJ, Carrillo MC, Johnson KA.

J Nucl Med. 2025 Jun 6;66(Suppl 2):S5-S31. doi: 10.2967/jnumed.124.268756.

Can ketamine therapy overcome treatment-resistant depression in Alzheimer's disease and older adults? Preclinical and clinical evidence

Mario A, Ivana L, Claudia MM, Antonello B, Francesco P, Tommaso C, Madia L.

Biomed Pharmacother. 2025 Jul;188:118199. doi: 10.1016/j.biopha.2025.118199. Epub 2025 May 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias